Literature DB >> 357681

Preliminary seroepidemiological studies on the human syncytial virus.

B G Achong, M A Epstein.   

Abstract

The seroepidemiology of the human syncytial virus was investigated by means of an indirect immunofluorescence test on 241 sera from Kenya, Tunisia, Singapore and Britain. These included sera from patients with nasopharyngeal carcinoma, other tumours of the oro-nasopharynx, tumours of other parts of the body, and from normal donors. In this study, the virus was found to infect only Kenyan Africans and all but one of these seropositive subjects had tumours, particularly of the oro-nasopharyngeal spaces. The significance of these findings is discussed.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 357681     DOI: 10.1099/0022-1317-40-1-175

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  5 in total

1.  Human foamy virus bel1 sequence in patients with autoimmune rheumatic diseases.

Authors:  Kuang-Hui Sun; Hsiao-Yi Lin; Lee-Wen Chen; Hsiao-Yun Tai; Mei-Lin Lin; Chi-Kuang Feng; Jung-Sung Sung; Hsin-Fu Liu; Wu-Tse Liu
Journal:  Clin Rheumatol       Date:  2005-12-20       Impact factor: 2.980

Review 2.  Historical perspective of foamy virus epidemiology and infection.

Authors:  C D Meiering; M L Linial
Journal:  Clin Microbiol Rev       Date:  2001-01       Impact factor: 26.132

3.  Isolation of a new foamy retrovirus from orangutans.

Authors:  M O McClure; P D Bieniasz; T F Schulz; I L Chrystie; G Simpson; A Aguzzi; J G Hoad; A Cunningham; J Kirkwood; R A Weiss
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

4.  Human spumavirus antibodies in sera from African patients.

Authors:  C Mahnke; P Kashaiya; J Rössler; H Bannert; A Levin; W A Blattner; M Dietrich; J Luande; M Löchelt; A E Friedman-Kien
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

Review 5.  Human RNA "rumor" viruses: the search for novel human retroviruses in chronic disease.

Authors:  Cécile Voisset; Robin A Weiss; David J Griffiths
Journal:  Microbiol Mol Biol Rev       Date:  2008-03       Impact factor: 13.044

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.